Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Global health sciences venture fund

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 14
Average round size
info
The average size of a deal this fund participated in
$25M
Portfolio companies 12
Rounds per year 2.00
Lead investments 2
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.14
Exits 2
Key employees Soon

Areas of investment

  • Biotechnology
  • Health Care
  • Therapeutics
  • Medical Device
  • Medical
Summary

The main office of represented VC is situated in the Vancouver. The venture was found in North America in Canada.

The standard case for the fund is to invest in rounds with 6-7 partakers. Despite the Global health sciences venture fund, startups are often financed by Quark Venture, Polaris Partners, NanoDimension. The meaningful sponsors for the fund in investment in the same round are Pontifax, Viva Ventures Biotech Group, Total Access Fund.

The important activity for fund was in 2018. The common things for fund are deals in the range of 10 - 50 millions dollars. The real fund results show that this VC is 20 percentage points more often commits exit comparing to other companies. The fund is constantly included in 2-6 investment rounds annually.

Besides, a startup needs to be aged 6-10 years to get the investment from the fund. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Among the various public portfolio startups of the fund, we may underline SQZ Biotech, Canary Medical, ABAC Therapeutics The fund has exact preference in a number of founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little. We can highlight the next thriving fund investment areas, such as Life Science, Medical.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Global health sciences venture fund:
Typical Co-investors
Global health sciences venture fund is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Global health sciences venture fund:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Angelor France, Lyon, Rhone-Alpes
Banco de Investimento Global Lisboa, Lisbon, Portugal
Beyond The Game Network Atlanta, Georgia, United States
Bonanza invest -
Carphone Warehouse England, London, United Kingdom
Elevation Investments Austria, Vienna
Geekhouse Capital Beijing, Beijing, China
InSite California, Redondo Beach, United States
Kitchen Fund New York, New York, United States
Markpoint Venture Partners Allen, Texas, United States
Maroon Venture Partners Fund Amherst, Massachusetts, United States
Mayhem Development Missouri, Springfield, United States
MBM Capital Partners England, London, United Kingdom
Old Kent Road (OKR) Financial Alberta, Calgary, Canada
Otter Rock Capital California, Los Angeles, United States
Palantir Capital California, Rancho Santa Fe, United States
Shenzhen Yidun Media Investment Fund China, Guangdong, Shenzhen
Supcon Group China, Hangzhou, Zhejiang
Venmo New York, New York, United States
Zibo Financial Holding -

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Variantyx

Biotechnology
Genetics
Health Care
Health Diagnostics
Information Technology
Life Science
Personal Health
$20M15 Mar 2021 Framingham, Massachusetts, United States

ARTMS

Health Care
Information Technology
$19M20 May 2020 Vancouver, British Columbia, Canada

Keros Therapeutics

Biotechnology
Health Care
Pharmaceutical
Therapeutics
$56M04 Mar 2020 Massachusetts, United States

EnClear Therapies

Biotechnology
Therapeutics
$10M19 Feb 2020 Cambridge, Massachusetts, United States

Volastra Therapeutics

Biotechnology
Medical
$12M11 Feb 2020 New York, New York, United States

Eyevensys

Biotechnology
Medical Device
Therapeutics
$30M08 Jan 2020 Ile-de-France

Keros Therapeutics

Biotechnology
Health Care
Pharmaceutical
Therapeutics
$23M08 Jan 2019 Massachusetts, United States

SQZ Biotech

Biotechnology
Life Science
Therapeutics
$72M08 Aug 2018 Massachusetts, United States

ABAC Therapeutics

Biotechnology
Life Science
Therapeutics
$18M15 Feb 2018 Barcelona, Catalonia, Spain

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Global health sciences venture fund?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 14
Average round size 25M
Rounds per year 2.00
Peak activity year 2020
Lead investments 2
Follow on index 0.14
Exits 2
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Variantyx

Biotechnology
Genetics
Health Care
Health Diagnostics
Information Technology
Life Science
Personal Health
$20M15 Mar 2021 Framingham, Massachusetts, United States

ARTMS

Health Care
Information Technology
$19M20 May 2020 Vancouver, British Columbia, Canada

Keros Therapeutics

Biotechnology
Health Care
Pharmaceutical
Therapeutics
$56M04 Mar 2020 Massachusetts, United States

EnClear Therapies

Biotechnology
Therapeutics
$10M19 Feb 2020 Cambridge, Massachusetts, United States

Volastra Therapeutics

Biotechnology
Medical
$12M11 Feb 2020 New York, New York, United States

Eyevensys

Biotechnology
Medical Device
Therapeutics
$30M08 Jan 2020 Ile-de-France

Keros Therapeutics

Biotechnology
Health Care
Pharmaceutical
Therapeutics
$23M08 Jan 2019 Massachusetts, United States

SQZ Biotech

Biotechnology
Life Science
Therapeutics
$72M08 Aug 2018 Massachusetts, United States

ABAC Therapeutics

Biotechnology
Life Science
Therapeutics
$18M15 Feb 2018 Barcelona, Catalonia, Spain
Crunchbase icon

Content report

The following text will be sent to our editors: